Ampalaya Use in Diabetes Mellitus
Prevention and treatment of diabetes mellitus are our major concerns of our organizations. We welcome a truly medicinal plant like ampalaya if scientifically proven and accepted in the treatment of diabetes. In 2003, we issued our position statement cautioning the public against indiscriminate use of the ampalaya-derived products in people with diabetes due to lack of sufficient evidence.
Position Statements
-
Glycohemoglobin Position Statement
Glycohemoglobin (GHb), also known as glycosylated hemoglobin and HbA1c, is a measure of 3 months glycemic control. The Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS) have established the importance of monitoring HbA1c concentrations in the development and progression of long-term complications.
